Evidence map›Paper›PMID 31634049›Full record

ArticleJournal of global oncology2019

Mapping Geospatial Access to Comprehensive Cancer Care in Nigeria.

Gregory C Knapp, Gavin Tansley, Olalekan Olasehinde, Olusegun I Alatise, Funmilola Wuraola, Moses O Olawole, Olujide O Arije, Bata M Gali, T Peter Kingham

Abstract read
In one paragraph

Article in Journal of global oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Gregory C KnappMemorial Sloan Kettering Cancer Center, New York, NY.
Gavin TansleyDalhousie University, Halifax, Nova Scotia, Canada.
Olalekan OlasehindeCollege of Health Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria.
Olusegun I AlatiseCollege of Health Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria.
Funmilola WuraolaCollege of Health Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria.
Moses O OlawoleCollege of Health Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria.
Olujide O ArijeCollege of Health Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria.
Bata M GaliUniversity of Maiduguri, Maiduguri, Nigeria.
T Peter KinghamMemorial Sloan Kettering Cancer Center, New York, NY.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

purposeTo address the increasing burden of cancer in Nigeria, the National Cancer Control Plan outlines the development of 8 public comprehensive cancer centers. We map population-level geospatial access to these eight centers and explore equity of access and the impact of future development.

methodsGeospatial methods were used to estimate population-level travel times to the 8 cancer centers. A cost distance model was built using open source road infrastructure data with verified speed limits. Geolocated population estimates were amalgamated with this model to calculate travel times to cancer centers at a national and regional level for both the entire population and the population living on < US$2 per day.

resultsOverall, 68.9% of Nigerians have access to a comprehensive cancer center at 4 hours of continuous vehicular travel. However, there is significant variability in access between geopolitical zones (

conclusionThe Federal Ministry of Health endorses investment in 8 public comprehensive cancer centers. Strengthening these centers will allow the majority of Nigerians to access the full complement of multidisciplinary care within a reasonable time frame. However, geospatial access remains inequitable, and the impact on outcomes is unclear. This must be considered as the cancer control system matures and expands.

Indexed as

HumansIncidenceNeoplasmsNigeria

Identifiers

PMID31634049
PMCPMC6825250

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.